2024 annual financial data
Nurix Therapeutics, Inc. 2024 Operating margin
Nurix Therapeutics, Inc. 2024 operating margin with verified reported values.
Direct answer
Operating margin was -390.52%.
Operating income was -213,027,000 USD and net income was -193,569,000 USD.
Operating cash flow was -172,584,000 USD.
Get free Nurix Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 54,549,000 USD
- Operating income
- -213,027,000 USD
- Net income
- -193,569,000 USD
- Operating cash flow
- -172,584,000 USD